Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 19892351)

1.

Statins improve visual field alterations related to hypercholesterolemia.

Alcalá A, Jansen S, Téllez T, Gómez-Huelgas R, Pérez O, Egido J, Farkouh ME.

Atherosclerosis. 2010 Apr;209(2):510-4. doi: 10.1016/j.atherosclerosis.2009.10.001. Epub 2009 Oct 12.

PMID:
19892351
2.

Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease.

Bak AA, Huizer J, Leijten PA, Rila H, Grobbee DE.

J Intern Med. 1998 Nov;244(5):371-8.

PMID:
9845852
3.

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.

Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.

Diabetes Obes Metab. 2000 Dec;2(6):355-62.

PMID:
11225965
4.

Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.

Sasaki S, Nakagawa M, Nakata T, Azuma A, Sawada S, Takeda K, Asayama J; Lipid Intrvention Study in Kyoto.

Circ J. 2002 Jan;66(1):47-52.

5.

Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.

Milani M, Cimminiello C, Merlo B, Lorena M, Arpaia G, Bonfardeci G.

Am J Cardiol. 1995 Jul 13;76(2):51A-53A.

PMID:
7604798
6.
7.

Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.

Sebestjen M, Boh M, Keber I.

Wien Klin Wochenschr. 2002 Dec 30;114(23-24):999-1003.

PMID:
12635468
8.

A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.

Davidson MH, Testolin LM, Maki KC, von Duvillard S, Drennan KB.

Arch Intern Med. 1997 Jun 9;157(11):1186-92.

PMID:
9183229
9.

Effect of a reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia.

Galvan AQ, Natali A, Baldi S, Frascerra S, Sampietro T, Galetta F, Seghieri G, Ferrannini E.

J Cardiovasc Pharmacol. 1996 Oct;28(4):595-602.

PMID:
8891888
10.

Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia.

Lee WJ, Lee WL, Tang YJ, Liang KW, Chien YH, Tsou SS, Sheu WH.

Clin Chim Acta. 2008 Apr;390(1-2):49-55. doi: 10.1016/j.cca.2007.12.013. Epub 2007 Dec 23.

PMID:
18201563
11.

Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.

Jacotot B, Benghozi R, Pfister P, Holmes D.

Am J Cardiol. 1995 Jul 13;76(2):54A-56A.

PMID:
7604799
12.

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.

Clin Ther. 2004 Sep;26(9):1388-99. Erratum in: Clin Ther. 2005 Jan;27(1):142.

PMID:
15531001
13.

Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.

Simons LA, Nestel PJ, Clifton P, Janus ED, Simons J, Parfitt A.

Med J Aust. 1992 Nov 2;157(9):584-9.

PMID:
1406416
14.
15.

Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.

Stender S, Schuster H, Barter P, Watkins C, Kallend D; MERCURY I Study Group.

Diabetes Obes Metab. 2005 Jul;7(4):430-8. Erratum in: Diabetes Obes Metab. 2005 Jul;7(4):460.

PMID:
15955130
16.

Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.

Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.

Int J Cardiol. 2005 Oct 10;104(3):338-45.

PMID:
16186066
17.

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study.

Hunninghake DB, Knopp RH, Schonfeld G, Goldberg AC, Brown WV, Schaefer EJ, Margolis S, Dobs AS, Mellies MJ, Insull W Jr, et al.

Atherosclerosis. 1990 Nov;85(1):81-9.

PMID:
2126437
18.

Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.

Pfeffer MA, Sacks FM, Moyé LA, East C, Goldman S, Nash DT, Rouleau JR, Rouleau JL, Sussex BA, Theroux P, Vanden Belt RJ, Braunwald E.

J Am Coll Cardiol. 1999 Jan;33(1):125-30.

PMID:
9935018
19.

Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.

Rader DJ, Davidson MH, Caplan RJ, Pears JS.

Am J Cardiol. 2003 Mar 6;91(5A):20C-23C; discussion 23C-24C.

PMID:
12646340
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk